European Journal of Gynaecological Oncology. 2026; 47(3): 163-163. doi: 10.22514/ejgo.2026.059
Correction

Correction: Risk factors contributing to the persistent infection of high-risk Human papillomavirus (HPV)

Ting Feng1, Yuhong Yang1,*,

1Department of Obstetrics and Gynecology, Hangzhou Women’s Hospital, 310008 Hangzhou, Zhejiang, China

*Corresponding Author(s):yyh522yh@163.com (Yuhong Yang)

History Published: 15 October 2026
Copyright:  ©2026 The Author(s). Published by MRE Press.
This is an open access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/).

Collapse table of contents

Abstract

No abstract available.

Keywords:None.
PDF(231.55 kB)|EndNote (RIS)|BibTeX|RefMan|RefWorks

Cite this article

Ting Feng, Yuhong Yang. Correction: Risk factors contributing to the persistent infection of high-risk Human papillomavirus (HPV). European Journal of Gynaecological Oncology. 2026; 47(3): 163-163. doi: 10.22514/ejgo.2026.059

The authors regret that in the original article [1], several references in Section 3.2 (Genetic susceptibility) were inappropriately cited due to oversight during the final editing process.

The corrected references are as follows:

[36] Wang Y, Yang Y, Jia X, Zhao C, Yang C, Fan J, et al. Identification of the shared genetic architecture underlying seven autoimmune diseases with GWAS summary statistics. Frontiers in Immunology. 2024; 14: 1303675.

[38] Zhou YY, Chang M, Li CP, Han XL, Fang P, Xia XP. Causal effect of age first had sexual intercourse and lifetime number of sexual partners on cervical cancer. Heliyon. 2023; 10: e23758.

[39] Li Q, Su M, Wang Y, Li Z, Song Y, Zhou B, et al. Association between TAB2 genetic polymorphisms and the susceptibility to cervical cancer: a case-control study. Cancer Cell International. 2024; 24: 413.

[40] Zhang XQ, Bai XH, Zhang HZ, He XF. Association between the p53 polymorphisms and cervical cancer risk: an updated meta-analysis. Frontiers in Oncology. 2025; 15: 1461737.

[41] Mostaid MS, Mumu SB, Haque MA, Sharmin S, Jamiruddin MR, Sayedur Rahman GM, et al. Elevated serum expression of p53 and association of TP53 codon 72 polymorphisms with risk of cervical cancer in Bangladeshi women. PLOS ONE. 2021; 16: e0261984.

[47] Au WW. Life style, environmental and genetic susceptibility to cervical cancer. Toxicology. 2004; 198: 117–120.

[50] Dancy E, Stratton P, Pichard DC, Marciano BE, Cowen EW, McBride AA, et al. Human papillomavirus disease in GATA2 deficiency: a genetic predisposition to HPV-associated female anogenital malignancy. Frontiers in Immunology. 2024; 15: 1445711.

[51] Souid M, Bday J, Souissi S, Ghedira R, Gabbouj S, Shini-Hadhri S, et al. Arginase is upregulated in healthy women infected by oncogenic HPV types. Biomarkers. 2023; 28: 628–636.

[59] Runge I, Klein JMA, Pannen AK, Abera S, Wakuma T, Gebrehiwot Y, et al. Prevalence of human papillomaviruses in self-collected samples among women attending antenatal care in Ethiopia: a cross-sectional study. Ecancermedicalscience. 2024; 18: 1739.

This correction does not affect the scientific findings, data, discussion, or conclusions of the original article. The authors sincerely apologize for any inconvenience or confusion caused by these errors.

References

Feng T, Yang YH. Risk factors contributing to the persistent infection of high-risk Human papillomavirus (HPV). European Journal of Gynaecological Oncology. 2025; 46: 1–7.

[Google Scholar]